Insider transactions

EDGAR

XENON PHARMACEUTICALS INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-16.

Open-market purchases (code P)
2 transactions, 45,000 shares
Sum of shares × price per share: 1,681,140
Open-market sales (code S)
26 transactions, 381,589 shares
Sum of shares × price per share: 21,969,162.6224

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 97

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-15 Filed 2026-10-16Kelly Thomas Patrick Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Shares
Acquired (A)7,500——22,500Direct (D) No
F1
  • F1 Represents shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on October 15, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on October 15, 2026.
Open filing 0001193125-26-424428 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-16Kelly Thomas Patrick Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Share Units — underlying Common Shares (7,500)
Disposed (D)7,5000—22,500Direct (D) No
F1
  • F1 Represents shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on October 15, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on October 15, 2026.
Open filing 0001193125-26-424428 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-01MORTIMER IAN Director · Officer: PRESIDENT CEO
P

Open market or private purchase of non-derivative or derivative security

Common Shares
Acquired (A)30,00037.38
1,121,400

Derived: shares × price per share. Exact value 1121400.00.

49,923Direct (D) No— Open filing 0001193125-26-409999 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-01Kelly Thomas Patrick Officer: Chief Financial Officer
P

Open market or private purchase of non-derivative or derivative security

Common Shares
Acquired (A)15,00037.316
559,740

Derived: shares × price per share. Exact value 559740.000.

15,000Direct (D) No— Open filing 0001193125-26-410001 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03Svoronos Dawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Shares
Acquired (A)5,1448.15
41,923.6

Derived: shares × price per share. Exact value 41923.60.

31,373Direct (D) No— Open filing 0001193125-26-382412 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03Svoronos Dawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Shares (5,144) — exercise price 8.15
Disposed (D)5,1440—0Direct (D) No
F1
  • F1 The shares subject to the option are fully vested and exercisable.
Open filing 0001193125-26-382412 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-31KENNEY CHRISTOPHER JOHN Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Shares
Disposed (D)6,36860.1673
383,145.3664

Derived: shares × price per share. Exact value 383145.3664.

702Direct (D) Yes
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.
  • F2 The Amount and Price reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $59.79 to $60.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open filing 0001193125-26-377309 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-31KENNEY CHRISTOPHER JOHN Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Shares
Disposed (D)70060.9766
42,683.62

Derived: shares × price per share. Exact value 42683.6200.

2Direct (D) Yes
F1, F3, F4
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.
  • F3 The Amount and Price reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $60.81 to $61.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • F4 The number of shares beneficially owned following the reported transactions reflects an upward adjustment of one share from the reporting person's previous Form 4 filed on March 13, 2026, based on updated tax withholding calculations for the transactions described on the previously filed Form 4.
Open filing 0001193125-26-377309 Read from the filing’s XML Dispute this row
2026-08-11 Filed 2026-08-13GANNON STEVEN Director
S

Open market or private sale of non-derivative or derivative security

Common Shares
Disposed (D)10,00064.055
640,550

Derived: shares × price per share. Exact value 640550.000.

1,870Direct (D) No
F1
  • F1 The Amount and Price reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $64.0517 to $64.078, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open filing 0001193125-26-349351 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08Cannon Gillian Director
S

Open market or private sale of non-derivative or derivative security

Common Shares
Disposed (D)1,19053.14
63,236.6

Derived: shares × price per share. Exact value 63236.60.

1,455Direct (D) Yes
F1
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 15, 2025, solely to satisfy income tax obligations related to the vesting of RSUs granted on June 5, 2025.
Open filing 0001193125-26-262671 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08PATOU GARY Director
S

Open market or private sale of non-derivative or derivative security

Common Shares
Disposed (D)1,32253.14
70,251.08

Derived: shares × price per share. Exact value 70251.08.

24,896Direct (D) Yes
F1
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 17, 2025, solely to satisfy income tax obligations related to the vesting of RSUs granted on June 5, 2025.
Open filing 0001193125-26-262672 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03GANNON STEVEN Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Share Option (Right to Buy) — underlying Common Shares (10,507) — exercise price 53.46
Acquired (A)10,5070—10,507Direct (D) No
F4
  • F4 Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.
Open filing 0001193125-26-256121 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03GANNON STEVEN Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Share Units — underlying Common Shares (1,593) — exercise price 0
Acquired (A)1,5930—1,593Direct (D) No
F5
  • F5 Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.
Open filing 0001193125-26-256121 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03GAROFALO ELIZABETH A. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Share Option (Right to Buy) — underlying Common Shares (10,507) — exercise price 53.46
Acquired (A)10,5070—10,507Direct (D) No
F2
  • F2 Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.
Open filing 0001193125-26-256122 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03GAROFALO ELIZABETH A. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Share Units — underlying Common Shares (1,593) — exercise price 0
Acquired (A)1,5930—1,593Direct (D) No
F3
  • F3 Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.
Open filing 0001193125-26-256122 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03Gover Justin D. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Share Option (Right to Buy) — underlying Common Shares (10,507) — exercise price 53.46
Acquired (A)10,5070—10,507Direct (D) No
F2
  • F2 Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.
Open filing 0001193125-26-256124 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03Gover Justin D. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Share Units — underlying Common Shares (1,593) — exercise price 0
Acquired (A)1,5930—1,593Direct (D) No
F3
  • F3 Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.
Open filing 0001193125-26-256124 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03Svoronos Dawn Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Share Option (Right to Buy) — underlying Common Shares (10,507) — exercise price 53.46
Acquired (A)10,5070—10,507Direct (D) No
F4
  • F4 Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.
Open filing 0001193125-26-256118 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03Svoronos Dawn Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Share Units — underlying Common Shares (1,593) — exercise price 0
Acquired (A)1,5930—1,593Direct (D) No
F5
  • F5 Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.
Open filing 0001193125-26-256118 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03Machado Patrick Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Share Option (Right to Buy) — underlying Common Shares (10,507) — exercise price 53.46
Acquired (A)10,5070—10,507Direct (D) No
F2
  • F2 Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.
Open filing 0001193125-26-256125 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03Machado Patrick Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Share Units — underlying Common Shares (1,593) — exercise price 0
Acquired (A)1,5930—1,593Direct (D) No
F3
  • F3 Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.
Open filing 0001193125-26-256125 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03PATOU GARY Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Share Option (Right to Buy) — underlying Common Shares (10,507) — exercise price 53.46
Acquired (A)10,5070—10,507Direct (D) No
F3
  • F3 Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.
Open filing 0001193125-26-256126 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03PATOU GARY Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Share Units — underlying Common Shares (1,593) — exercise price 0
Acquired (A)1,5930—1,593Direct (D) No
F4
  • F4 Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.
Open filing 0001193125-26-256126 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03Cannon Gillian Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Share Option (Right to Buy) — underlying Common Shares (10,507) — exercise price 53.46
Acquired (A)10,5070—10,507Direct (D) No
F2
  • F2 Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.
Open filing 0001193125-26-256120 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03Cannon Gillian Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Share Units — underlying Common Shares (1,593) — exercise price 0
Acquired (A)1,5930—1,593Direct (D) No
F3
  • F3 Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders.
Open filing 0001193125-26-256120 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03GANNON STEVEN Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Shares
Acquired (A)2,645——13,286Direct (D) No
F1
  • F1 Represents Common Shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.
Open filing 0001193125-26-256121 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03GANNON STEVEN Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)1,41653.41
75,628.56

Derived: shares × price per share. Exact value 75628.56.

11,870Direct (D) No
F2, F3
  • F2 Represents the number of Common Shares withheld by the issuer to satisfy income tax withholding and remittance obligations in connection with the net settlement of the RSUs, and does not represent a sale.
  • F3 Represents the closing price of Common Shares on June 1, 2026 for purposes of net settlement calculations.
Open filing 0001193125-26-256121 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03GANNON STEVEN Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Share Units — underlying Common Shares (2,645)
Disposed (D)2,6450—0Direct (D) No
F1
  • F1 Represents Common Shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.
Open filing 0001193125-26-256121 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03GAROFALO ELIZABETH A. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Shares
Acquired (A)2,645——2,645Direct (D) No
F1
  • F1 Represents Common Shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.
Open filing 0001193125-26-256122 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03GAROFALO ELIZABETH A. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Share Units — underlying Common Shares (2,645)
Disposed (D)2,6450—0Direct (D) No
F1
  • F1 Represents Common Shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.
Open filing 0001193125-26-256122 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03Gover Justin D. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Shares
Acquired (A)2,645——2,645Direct (D) No
F1
  • F1 Represents Common Shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.
Open filing 0001193125-26-256124 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03Gover Justin D. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Share Units — underlying Common Shares (2,645)
Disposed (D)2,6450—0Direct (D) No
F1
  • F1 Represents Common Shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.
Open filing 0001193125-26-256124 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03Svoronos Dawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Shares
Acquired (A)2,645——27,645Direct (D) No
F1
  • F1 Represents Common Shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.
Open filing 0001193125-26-256118 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03Svoronos Dawn Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)1,41653.41
75,628.56

Derived: shares × price per share. Exact value 75628.56.

26,229Direct (D) No
F2, F3
  • F2 Represents the number of Common Shares withheld by the issuer to satisfy income tax withholding and remittance obligations in connection with the net settlement of the RSUs, and does not represent a sale.
  • F3 Represents the closing price of Common Shares on June 1, 2026 for purposes of net settlement calculations.
Open filing 0001193125-26-256118 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03Svoronos Dawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Share Units — underlying Common Shares (2,645)
Disposed (D)2,6450—0Direct (D) No
F1
  • F1 Represents Common Shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.
Open filing 0001193125-26-256118 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03Machado Patrick Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Shares
Acquired (A)2,645——2,645Direct (D) No
F1
  • F1 Represents Common Shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.
Open filing 0001193125-26-256125 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03Machado Patrick Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Share Units — underlying Common Shares (2,645)
Disposed (D)2,6450—0Direct (D) No
F1
  • F1 Represents Common Shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.
Open filing 0001193125-26-256125 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03PATOU GARY Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Shares
Acquired (A)2,645——26,218Direct (D) No
F1
  • F1 Represents Common Shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.
Open filing 0001193125-26-256126 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03PATOU GARY Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Share Units — underlying Common Shares (2,645)
Disposed (D)2,6450—0Direct (D) No
F1
  • F1 Represents Common Shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.
Open filing 0001193125-26-256126 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03Cannon Gillian Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Shares
Acquired (A)2,645——2,645Direct (D) No
F1
  • F1 Represents Common Shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.
Open filing 0001193125-26-256120 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03Cannon Gillian Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Share Units — underlying Common Shares (2,645)
Disposed (D)2,6450—0Direct (D) No
F1
  • F1 Represents Common Shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.
Open filing 0001193125-26-256120 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-05-13GANNON STEVEN Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Shares
Acquired (A)3,5007.38
25,830

Derived: shares × price per share. Exact value 25830.00.

10,641Direct (D) No— Open filing 0001193125-26-222369 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-05-13GANNON STEVEN Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Shares (3,500) — exercise price 7.38
Disposed (D)3,5000—0Direct (D) No
F1
  • F1 The shares subject to the option are fully vested and exercisable.
Open filing 0001193125-26-222369 Read from the filing’s XML Dispute this row
2026-03-13 Filed 2026-03-13MORTIMER IAN Director · Officer: PRESIDENT CEO
S

Open market or private sale of non-derivative or derivative security

Common Shares
Disposed (D)7,30855.225
403,584.3

Derived: shares × price per share. Exact value 403584.300.

19,923Direct (D) Yes
F2
  • F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of RSUs granted on March 12, 2025.
Open filing 0001193125-26-106724 Read from the filing’s XML Dispute this row
2026-03-13 Filed 2026-03-13DiFabio Andrea Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Common Shares
Disposed (D)1,34255.225
74,111.95

Derived: shares × price per share. Exact value 74111.950.

7,301Direct (D) Yes
F2
  • F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of RSUs granted on March 12, 2025.
Open filing 0001193125-26-106726 Read from the filing’s XML Dispute this row
2026-03-13 Filed 2026-03-13KENNEY CHRISTOPHER JOHN Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Shares
Disposed (D)1,41055.225
77,867.25

Derived: shares × price per share. Exact value 77867.250.

7,069Direct (D) Yes
F2
  • F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of RSUs granted on March 12, 2025.
Open filing 0001193125-26-106727 Read from the filing’s XML Dispute this row
2026-03-12 Filed 2026-03-13MORTIMER IAN Director · Officer: PRESIDENT CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Shares
Acquired (A)12,500——27,231Direct (D) Yes
F1
  • F1 Represents shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026.
Open filing 0001193125-26-106724 Read from the filing’s XML Dispute this row
2026-03-12 Filed 2026-03-13MORTIMER IAN Director · Officer: PRESIDENT CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Share Units — underlying Common Shares (12,500)
Disposed (D)12,5000—37,500Direct (D) Yes
F1
  • F1 Represents shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026.
Open filing 0001193125-26-106724 Read from the filing’s XML Dispute this row
2026-03-12 Filed 2026-03-13DiFabio Andrea Officer: Chief Legal Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Shares
Acquired (A)3,750——8,643Direct (D) Yes
F1
  • F1 Represents shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026.
Open filing 0001193125-26-106726 Read from the filing’s XML Dispute this row
2026-03-12 Filed 2026-03-13DiFabio Andrea Officer: Chief Legal Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Share Units — underlying Common Shares (3,750)
Disposed (D)3,7500—11,250Direct (D) Yes
F1
  • F1 Represents shares earned and vested under a restricted share unit (RSU) award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026.
Open filing 0001193125-26-106726 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 7,211 filings read, the latest filed 2026-11-13. Prior quarter ending 2026-06-30: 9,150 filings read.

Showing 1–50 of 204

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
FMR LLC Partly reported under another manager11,554,454 SH429,710,151 dollarsHigher by 1,906,456 Prior quarter: 9,647,998Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
BlackRock, Inc. Partly reported under another manager7,710,413 SH286,750,244 dollarsHigher by 187,931 Prior quarter: 7,522,482Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Capital International Investors Partly reported under another manager2,359,559 SH87,751,999 dollarsLower by 2,080 Prior quarter: 2,361,639Open filing 0001562230-26-000136 Filed 2026-11-12 Dispute this row
STATE STREET CORP Partly reported under another manager2,057,284 SH76,501,466 dollarsHigher by 87,655 Prior quarter: 1,969,629Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
Affinity Asset Advisors, LLC 1,900,374 SH70,674,909 dollarsHigher by 305,374 Prior quarter: 1,595,000Open filing 0001011438-26-000687 Filed 2026-11-13 Dispute this row
WESTFIELD CAPITAL MANAGEMENT CO LP 1,778,958 SH66,159,448 dollarsHigher by 271,664 Prior quarter: 1,507,294Open filing 0001177719-26-000022 Filed 2026-11-12 Dispute this row
Pictet Asset Management Holding SA 1,468,072 SH54,611,522 dollarsHigher by 280,349 Prior quarter: 1,187,723Open filing 0001993888-26-000007 Filed 2026-11-03 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager1,444,408 SH56,606,349 dollarsHigher by 6,696 Prior quarter: 1,437,712Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager1,386,148 SH51,546,312 dollarsHigher by 16,034 Prior quarter: 1,370,114Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Partly reported under another manager1,345,398 SH50,035,352 dollarsHigher by 54,667 Prior quarter: 1,290,731Open filing 0001520354-26-000046 Filed 2026-11-13 Dispute this row
FEDERATED HERMES, INC. Partly reported under another manager1,021,216 SH37,979,023 dollarsHigher by 137,479 Prior quarter: 883,737Open filing 0001623632-26-001675 Filed 2026-11-12 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager957,602 SH35,613,293 dollarsHigher by 73,283 Prior quarter: 884,319Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager897,509 SH33,378,361 dollarsHigher by 208,167 Prior quarter: 689,342Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager882,964 SH32,890,411 dollarsLower by 1,734,396 Prior quarter: 2,617,360Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 757,507 SH28,171,685 dollarsHigher by 7,856 Prior quarter: 749,651Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
PANAGORA ASSET MANAGEMENT INC 724,093 SH26,929,019 dollarsHigher by 60,062 Prior quarter: 664,031Open filing 0000883677-26-000011 Filed 2026-11-12 Dispute this row
Siren, L.L.C. Partly reported under another manager718,306 SH26,713,800 dollarsLower by 600,258 Prior quarter: 1,318,564Open filing 0002005245-26-000013 Filed 2026-11-12 Dispute this row
Invesco Ltd. Partly reported under another manager638,575 SH23,748,606 dollarsLower by 264,883 Prior quarter: 903,458Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
Capricorn Fund Managers Ltd Partly reported under another manager568,800 SH21,153,672 dollarsHigher by 547,900 Prior quarter: 20,900Open filing 0001901361-26-000016 Filed 2026-11-03 Dispute this row
MORGAN STANLEY Partly reported under another manager564,251 SH20,984,559 dollarsHigher by 157,994 Prior quarter: 406,257Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Capital World Investors Partly reported under another manager530,551 SH19,731,192 dollarsLower by 332,224 Prior quarter: 862,775Open filing 0001422849-26-000169 Filed 2026-11-12 Dispute this row
Qube Research Technologies Ltd 476,992 SH17,739,332 dollarsNot in the prior quarter’s filings read Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
BARCLAYS PLC Partly reported under another manager472,443 SH17,570,155 dollarsHigher by 452,397 Prior quarter: 20,046Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
Candriam S.C.A. 461,498 SH17,225,819 dollarsLower by 1,270 Prior quarter: 462,768Open filing 0001537014-26-000009 Filed 2026-11-03 Dispute this row
Nuveen, LLC Partly reported under another manager441,207 SH16,408,488 dollarsLower by 551,919 Prior quarter: 993,126Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
Fiera Capital Corp Partly reported under another manager411,032 SH15,286,280 dollarsHigher by 5,394 Prior quarter: 405,638Open filing 0001505817-26-000019 Filed 2026-11-06 Dispute this row
TimesSquare Capital Management, LLC Partly reported under another manager405,921 SH15,096,202 dollarsLower by 45,672 Prior quarter: 451,593Open filing 0001193125-26-444305 Filed 2026-11-03 Dispute this row
NEXTBio Capital Management LP 310,225 SH11,537,268 dollarsHigher by 127,000 Prior quarter: 183,225Open filing 0001172661-26-004969 Filed 2026-11-13 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager277,200 SH10,309,068 dollarsHigher by 90,090 Prior quarter: 187,110Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
NAN FUNG TRINITY (HK) LTD 247,765 SH9,214,380 dollarsUnchanged Prior quarter: 247,765Open filing 0001420506-26-002513 Filed 2026-11-06 Dispute this row
Allspring Global Investments Holdings, LLC Partly reported under another manager247,330 SH9,628,557 dollarsHigher by 12,918 Prior quarter: 234,412Open filing 0001890906-26-000078 Filed 2026-11-04 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager247,187 SH9,192,880 dollarsLower by 174,331 Prior quarter: 421,518Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
DNB ASSET MANAGEMENT AS 242,599 SH9,022,257 dollarsHigher by 42,148 Prior quarter: 200,451Open filing 0000912282-26-001448 Filed 2026-11-12 Dispute this row
HRT FINANCIAL LP 242,218 SH9,008 dollarsHigher by 155,718 Prior quarter: 86,500Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
Aberdeen Group plc Partly reported under another manager236,370 SH8,790,600 dollarsLower by 172,366 Prior quarter: 408,736Open filing 0001716774-26-000032 Filed 2026-11-10 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager236,073 SH8,779,554 dollarsHigher by 44,947 Prior quarter: 191,126Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
Russell Investments Group, Ltd. Partly reported under another manager198,100 SH7,372,818 dollarsHigher by 44,873 Prior quarter: 153,227Open filing 0001193125-26-451241 Filed 2026-11-06 Dispute this row
Jump Financial, LLC Partly reported under another manager195,278 SH7,262,388 dollarsLower by 65,452 Prior quarter: 260,730Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row
PEREGRINE CAPITAL MANAGEMENT LLC 185,959 SH6,915,815 dollarsHigher by 21,065 Prior quarter: 164,894Open filing 0000764529-26-000008 Filed 2026-11-09 Dispute this row
Swiss National Bank 166,100 SH6,177,259 dollarsHigher by 3,400 Prior quarter: 162,700Open filing 0001582202-26-000008 Filed 2026-11-12 Dispute this row
SEI INVESTMENTS CO Partly reported under another manager148,884 SH5,536,802 dollarsHigher by 29,633 Prior quarter: 119,251Open filing 0000350894-26-000059 Filed 2026-11-10 Dispute this row
KBC Group NV Partly reported under another manager129,609 SH4,820 dollarsHigher by 599 Prior quarter: 129,010Open filing 0001193125-26-428470 Filed 2026-10-22 Dispute this row
ALPS ADVISORS INC 128,289 SH4,771,068 dollarsHigher by 30,679 Prior quarter: 97,610Open filing 0001398344-26-019318 Filed 2026-11-03 Dispute this row
RHUMBLINE ADVISERS 123,191 SH4,581,461 dollarsLower by 207 Prior quarter: 123,398Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row
TD ASSET MANAGEMENT INC 113,246 SH4,218,414 dollarsHigher by 103,846 Prior quarter: 9,400Open filing 0001193125-26-460060 Filed 2026-11-13 Dispute this row
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 108,594 SH4,038,611 dollarsLower by 1,009 Prior quarter: 109,603Open filing 0001193125-26-429511 Filed 2026-10-23 Dispute this row
AXIOM INVESTORS LLC /DE 97,135 SH3,612,451 dollarsLower by 11,103 Prior quarter: 108,238Open filing 0001109147-26-000007 Filed 2026-11-12 Dispute this row
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 95,954 SH3,568,529 dollarsHigher by 3,214 Prior quarter: 92,740Open filing 0001081019-26-000023 Filed 2026-11-13 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager94,419 SH3,511,888 dollarsHigher by 57,824 Prior quarter: 36,595Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
VANGUARD FIDUCIARY TRUST CO 90,376 SH3,361,083 dollarsLower by 2,502 Prior quarter: 92,878Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Avoro Capital Advisors LLC 5,777,777 SH
  • Polar Capital Holdings Plc 4,570,556 SH
  • Driehaus Capital Management LLC 4,418,557 SH
  • Jupiter Topco LLC 4,186,519 SH
  • PRICE T ROWE ASSOCIATES INC /MD/ 3,248,219 SH
  • T. Rowe Price Investment Management, Inc. 2,168,581 SH
  • TWO SIGMA INVESTMENTS, LP 1,642,848 SH
  • DEERFIELD MANAGEMENT COMPANY, L.P. 1,615,696 SH
  • ALLIANCEBERNSTEIN L.P. 1,562,276 SH
  • WELLINGTON MANAGEMENT GROUP LLP 1,425,492 SH
  • CITADEL ADVISORS LLC 1,401,242 SH
  • BRAIDWELL LP 1,131,452 SH
  • ORBIMED ADVISORS LLC 892,471 SH
  • Caligan Partners LP 889,944 SH
  • GOLDMAN SACHS GROUP INC 773,625 SH
  • Caption Management, LLC 728,000 SH
  • Vestal Point Capital, LP 700,000 SH
  • Alyeska Investment Group, L.P. 697,692 SH
  • Rock Springs Capital Management LP 683,907 SH
  • NORTHERN TRUST CORP 671,566 SH
  • First Turn Management, LLC 600,200 SH
  • TUDOR INVESTMENT CORP ET AL 545,387 SH
  • LOOMIS SAYLES CO L P 527,273 SH
  • Octagon Capital Advisors LP 490,000 SH
  • NOVO HOLDINGS A/S 485,438 SH
  • Logos Global Management LP 450,000 SH
  • Trails Edge Capital Partners, LP 440,000 SH
  • ALGERT GLOBAL LLC 419,773 SH
  • BANK OF AMERICA CORP /DE/ 404,067 SH
  • Parkman Healthcare Partners LLC 397,379 SH
  • Nicholas Investment Partners, LP 395,844 SH
  • MILLENNIUM MANAGEMENT LLC 376,777 SH
  • UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 374,748 SH
  • BAKER BROS. ADVISORS LP 370,208 SH
  • Jones Hill Capital LP 367,900 SH
  • AMERIPRISE FINANCIAL INC 318,548 SH
  • Man Group plc 310,617 SH
  • ADAGE CAPITAL PARTNERS GP, L.L.C. 300,000 SH
  • Soleus Capital Management, L.P. 267,000 SH
  • DAFNA Capital Management LLC 250,772 SH
  • Sixth Street Partners Management Company, L.P. 249,473 SH
  • CHARLES SCHWAB INVESTMENT MANAGEMENT INC 249,473 SH
  • STATE OF WISCONSIN INVESTMENT BOARD 248,821 SH
  • Duquesne Family Office LLC 238,600 SH
  • Redmile Group, LLC 229,374 SH
  • Schonfeld Strategic Advisors LLC 227,330 SH
  • D. E. Shaw Co., Inc. 223,922 SH
  • Patient Square Capital LP 220,000 SH
  • NEW YORK STATE COMMON RETIREMENT FUND 210,471 SH
  • JENNISON ASSOCIATES LLC 208,060 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
T. Rowe Price Investment Management, Inc. COMMON STOCK10.39,996,12410/31/2026 Filed 2026-11-06SCHEDULE 13G/AAmendment 1Open filing 0001897612-26-000704 Dispute this row
T. Rowe Price Investment Management, Inc. COMMON STOCK8.27,905,75709/30/2026 Filed 2026-11-06SCHEDULE 13GOpen filing 0001897612-26-000699 Dispute this row
FMR LLC COMMON STOCK11.511,136,649.1709/30/2026 Filed 2026-11-05SCHEDULE 13G/AAmendment 9Open filing 0000315066-26-002888 Dispute this row
Abigail P. Johnson COMMON STOCK11.511,136,649.1709/30/2026 Filed 2026-11-05SCHEDULE 13G/AAmendment 9Open filing 0000315066-26-002888 Dispute this row
FMR LLC COMMON STOCK10.39,959,795.1707/31/2026 Filed 2026-08-07SCHEDULE 13G/AAmendment 8Open filing 0000315066-26-002245 Dispute this row
Abigail P. Johnson COMMON STOCK10.39,959,795.1707/31/2026 Filed 2026-08-07SCHEDULE 13G/AAmendment 8Open filing 0000315066-26-002245 Dispute this row
Wellington Management Group LLP Common Stock1.51,425,492.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 1Open filing 0000902219-26-000248 Dispute this row
Wellington Group Holdings LLP Common Stock1.51,425,492.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 1Open filing 0000902219-26-000248 Dispute this row
Wellington Investment Advisors Holdings LLP Common Stock1.51,425,492.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 1Open filing 0000902219-26-000248 Dispute this row
FMR LLC COMMON STOCK9.99,599,498.0006/30/2026 Filed 2026-08-06SCHEDULE 13G/AAmendment 7Open filing 0000315066-26-002171 Dispute this row
Abigail P. Johnson COMMON STOCK9.99,599,498.0006/30/2026 Filed 2026-08-06SCHEDULE 13G/AAmendment 7Open filing 0000315066-26-002171 Dispute this row
Avoro Capital Advisors LLC Common Shares, no par value per share6.265,777,777.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 5Open filing 0000902664-26-002464 Dispute this row
Behzad Aghazadeh Common Shares, no par value per share6.265,777,777.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 5Open filing 0000902664-26-002464 Dispute this row
JANUS HENDERSON GROUP PLC Common Shares4.54,175,98203/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0001274173-26-000118 Dispute this row
DRIEHAUS CAPITAL MANAGEMENT LLC Common Stock4.874,491,65312/31/2025 Filed 2026-05-15SCHEDULE 13G/AAmendment 3Open filing 0000938206-26-000027 Dispute this row
Wellington Management Group LLP Common Stock6.24,764,779.0012/31/2025 Filed 2026-02-10SCHEDULE 13GOpen filing 0000902219-26-000084 Dispute this row
Wellington Group Holdings LLP Common Stock6.24,764,779.0012/31/2025 Filed 2026-02-10SCHEDULE 13GOpen filing 0000902219-26-000084 Dispute this row
Wellington Investment Advisors Holdings LLP Common Stock6.24,764,779.0012/31/2025 Filed 2026-02-10SCHEDULE 13GOpen filing 0000902219-26-000084 Dispute this row
Wellington Management Company LLP Common Stock6.04,764,779.0012/31/2025 Filed 2026-02-10SCHEDULE 13GOpen filing 0000902219-26-000084 Dispute this row
JANUS HENDERSON GROUP PLC Common Stock5.13,943,88509/30/2025 Filed 2025-11-14SCHEDULE 13GOpen filing 0001274173-25-000274 Dispute this row
Wellington Management Group LLP Common Stock2.82,174,761.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 1Open filing 0000902219-25-000271 Dispute this row
Wellington Group Holdings LLP Common Stock2.82,174,761.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 1Open filing 0000902219-25-000271 Dispute this row
Wellington Investment Advisors Holdings LLP Common Stock2.82,174,761.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 1Open filing 0000902219-25-000271 Dispute this row
FMR LLC COMMON STOCK11.58,824,363.0006/30/2025 Filed 2025-08-06SCHEDULE 13G/AAmendment 6Open filing 0000315066-25-002142 Dispute this row
Abigail P. Johnson COMMON STOCK11.58,824,363.0006/30/2025 Filed 2025-08-06SCHEDULE 13G/AAmendment 6Open filing 0000315066-25-002142 Dispute this row
BlackRock, Inc. Common Stock6.24,757,70906/30/2025 Filed 2025-07-17SCHEDULE 13GOpen filing 0002052113-25-002959 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,045,099 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
202240,015
2023199,811
2024138,788
2025235,520
2026254,026

Filings made before the SEC required XML are listed, not extracted.

Back to XENON PHARMACEUTICALS INC.